Nike: Just Can’t Do It In China

Summary:

  • In 1Q25, Nike generated revenues of $11.58 billion, declining by 10.43% and 8.07% year-on-year and quarter-on-quarter, respectively.
  • Despite an improvement in gross margin, operating margin deteriorated due to higher SG&A spending to capture demand.
  • Although the company has multiple initiatives to restore growth, consumer sentiment will continue to weigh on NKE’s sales.
  • In China, domestic competitors have outperformed, and the Company must figure out a way to generate growth amidst poor macroeconomic conditions and changing consumer patterns.
  • Valuation analysis suggests that NKE’s valuation does not reflect a deterioration of the company and does not provide any margin of safety.

Man walking in front of a NIKE retail store at night

ozgurdonmaz/iStock Unreleased via Getty Images

Introduction

Nike (NYSE:NKE) (NEOE:NKE:CA) is one of the world’s most renowned brands and engage in the development and sale of athletics products including footwear, apparel, equipment, and accessories. Since November 2021, the company’s share price has fallen


Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.


Leave a Reply

Your email address will not be published. Required fields are marked *